Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patientsCatherine Patte, Mitchell S. Cairo, Anne Aupérin et al.|Blood|2006Cited by 431
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescentsMitchell S. Cairo, Catherine Patte, Mary Gerrard et al.|Blood|2006Cited by 362
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges AheadVéronique Minard‐Colin, Catherine Patte, Laurence Brugières et al.|Journal of Clinical Oncology|2015Cited by 288
Revised International Pediatric Non-Hodgkin Lymphoma Staging SystemAngelo Rosolen, Mitchell S. Cairo, Sherrie L. Perkins et al.|Journal of Clinical Oncology|2015Cited by 238
Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot StudyElizabeth A. Raetz, Peter C. Adamson, Mitchell S. Cairo et al.|Journal of Clinical Oncology|2008Cited by 210